Navigation Links
China Pharma Holdings, Inc., Financial Year 2008 Preview
Date:1/21/2009

HAIKOU CITY, China, Jan. 21 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced a financial preview.

According to the unaudited financial data for the financial year 2008, China Pharma achieved record high revenues. The Company's work to strengthen accounts receivable collection led to clear improvements in collection, and effective control of accounts receivable. The Company also realized record high positive cash flow in operating activity. The sales revenue improved by over 50% compared to the previous year, while the net income improved by over 35% compared to the previous year.

China Pharma's President and CEO, Ms. Zhilin Li commented, ''I am very happy to announce record-breaking revenue for the financial year 2008, and also the success of our efforts to strengthen the collection of accounts receivable and to achieve record high positive operating cash flow. Our deepened penetration into our broad distribution network, and our strong sales force positioned us to gain greater market share. In addition, our diverse product mix addressing diseases of greatest incidence and highest mortality in China has allowed us to generate more brand awareness on an ongoing basis. Our new products with high market potential to be launched this year will support our strong financial performance.''

The Company expects to announce more detailed information including audited fourth quarter and full year 2008 results in a press release and conference call to be scheduled in March 2009.

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high margin business model is driven by market demand and supported by a scalable GMP-certified manufacturing infrastructure. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Bio-pharmaceutical Co., Ltd (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com.

Safe Harbor Statement: Certain statements in this press release and oral statements made by China Pharma on its conference call in relation to this release, constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, which may include, but are not limited to, such factors as unanticipated changes in product demand, increased competition, failure to obtain or maintain intellectual property protection, downturns in the Chinese economy, uncompetitive levels of research and development, failure to obtain regulatory approvals, and other information detailed from time to time in the Company's filings and future filings with the United States Securities and Exchange Commission. The forward-looking statements made herein speak only as of the date of this press release and the Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations.

    For more information, please contact:

    China Pharma Holdings, Inc.
     Diana Huang
     Tel:   +86-898-6681-1730
     Email: hps@chinapharmaholdings.com

    The Ruth Group
     Sara Ephraim
     Tel:   +1-646-536-7002
     Email: sephraim@theruthgroup.com

'/>"/>
SOURCE China Pharma Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... announced that it is launching a new client service center in La Vergne, ... Texas, and will provide the full range of Empyrean client services. , “Our ...
(Date:5/3/2016)... GA (PRWEB) , ... May 03, 2016 , ... Nationally recognized personal injury law firm ... Day weekend by giving free roses to anyone who wants one for their Mother or ... we recognize the important valuable contributions of Mothers.” Monge goes on to say, “we ...
(Date:5/3/2016)... Texas (PRWEB) , ... May 03, 2016 , ... Park ... that live in or adjacent to the 75204, 75205, 75206, 75209, 75219, 75220, 75225, ... Lawn/Uptown, Greenway Parks, Bluffview, Midway Hollow, North Dallas, Plano, Preston Hollow and Park Cities ...
(Date:5/3/2016)... ... 2016 , ... United Benefit Advisors (UBA), the nation’s leading ... addition to its elite stable of Partner Firms. Benefits Alliance Insurance Services is ... Paul Vincent. The Firm is also led by industry and thought-leading COO Steve ...
(Date:5/3/2016)... ... May 03, 2016 , ... For the sixth ... and Communication Technology (ICT) companies in the annual Branham300 listing. For 23 years, ... Canada, as ranked by revenue. , “We are honored to be on ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 3, 2016 BioNovus ... Center,s Institute for Advancing Medical Innovation (IAMI) today ... new drugs, diagnostics and medical devices. ... Innovations with rights to license, develop and commercialize ... "This partnership represents a significant ...
(Date:5/3/2016)... , May 4, 2016 ... "Global Cancer Stem Cell Therapy Market Outlook 2020" ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,Recombinant technology has improved ... are expected to be developed in coming years. Many ... techniques. Cancer stem cell therapies are also expected to ...
(Date:5/3/2016)... a major investment from Sino-German High-Tech Fund to further expand product development, strengthen its disease modeling capabilities and increase ... ... ... ... ...
Breaking Medicine Technology: